Because states don’t have enough of the opioid overdose antidote, Remedy Alliance negotiates with naloxone manufacturers to lower prices and then sells it to community groups and local governments. The organization formed in 2008 as the Opioid Safety and Naloxone Network Buyers Club.
Remedy Alliance is responsible for “a substantial portion” of the nation’s naloxone supply, Susan Winckler, the CEO of the FDA’s Reagan-Udall Foundation, told the Post.
Between 2017 and 2021, the nonprofit sold more than 4 million doses, according to its website.
“The affordable naloxone shortage is officially over,” Remedy Alliance’s organizers told the Post.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
